Back to Search
GEORGE TIDMARSH, M.D.
M.D.
Neonatal-Perinatal Medicine Physician
NPI: 1427502186Individual
Specialties, Licenses & Credentials
Neonatal-Perinatal Medicine PhysicianPrimary
Pediatrics — Neonatal-Perinatal Medicine
Code: 2080N0001X
G68589(CA)
Research & Publications (10)
A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabine.
PMID 19188061·Eur J Cancer·2009
3-trial
Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions.
PMID 18337683·Q J Nucl Med Mol Imaging·2009
3-trial
A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma.
PMID 17661038·Cancer Chemother Pharmacol·2008
3-trial
A novel alkylating agent, glufosfamide, enhances the activity of gemcitabine in vitro and in vivo.
PMID 17786181·Neoplasia·2007
4-observational
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
PMID 16110029·J Clin Oncol·2005
3-trial
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
PMID 14729604·Cancer Res·2004
7-preclinical
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.
PMID 11579112·J Clin Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10182 TELESIS CT
SAN DIEGO, CA 92121 - Phone
- (650) 208-3191
Quick Facts
- NPI
- 1427502186
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 10
Are you this provider?
Claim Your Profile